EUVIMEDEUVIMED entdecken
Crossref

Smart Tumor Oxygen Supply Strategy Enables Dual‐Modality Fluorescence/MR Imaging and Synergistic Therapy of Triple‐Negative Breast Cancer

Hao Cui, Chen Ni, Mengmeng Wang, Jie Huang, Danyang Qu, Jinfeng Yang, Xingqi Pan, Zhenbao Liu iD, Meilin Shi iD

Advanced Healthcare Materials · 2026

DOI: 10.1002/adhm.202503886 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Hao Cui und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Medical Imaging, Xuzhou Medical University, Xuzhou, Jiangsu, 221004, China. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Magnetic Resonance Imaging, Oxygen, Optical Imaging. Die Arbeit nennt 39 Literaturangaben. Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation, Postdoctoral Research Funding Program of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer progression is closely associated with hypoxia, which severely limits the efficacy of conventional therapy. In addition, the lack of real‐time imaging hampers accurate monitoring of therapeutic processes, further reducing treatment precision and efficacy. Here, the rational design of a multifunctional nanoplatform that integrates hypoxia relief, dual‐modality imaging, and synergistic therapy to overcome these barriers is reported. Mesoporous polydopamine nanoparticles are engineered and sequentially functionalized with the sonosensitizer chlorin e6 (Ce6), oxygen‐generating manganese dioxide, and the targeting antibody cetuximab, yielding MPDA‐Ce6@MnO 2 ‐C225 (MCMC NPs). This construct exhibits a uniform nanoflower‐like architecture, high Ce6 encapsulation efficiency, and robust oxygen supply capacity. By simultaneously enhancing reactive oxygen species generation and chemodynamic activity, MCMC NPs achieve potent SDT/CDT synergy under ultrasound activation. Importantly, they provide sensitive dual‐modality fluorescence and magnetic resonance (MR) imaging, enabling real‐time monitoring of nanoparticle distribution and therapeutic response. In vitro studies confirm excellent biocompatibility, targeted uptake by 4T1 breast cancer cells, and significant MRI signal enhancement. In vivo, MCMC NPs effectively alleviate tumor hypoxia, markedly suppress tumor growth, and prolong therapeutic response. This study establishes MCMC NPs as a versatile nanotheranostic platform that integrates imaging with oxygen‐augmented SDT/CDT, offering a promising strategy for precise and effective breast cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsMagnetic Resonance ImagingOxygenOptical ImagingAnimalsFemaleNanoparticlesCell Line, TumorMiceChlorophyllidesHumansManganese CompoundsIndolesOxidesPolymersPorphyrinsMice, Inbred BALB CReactive Oxygen Species

Stichwörter der Autor:innen

dual‐modality fluorescence/MR imagingmanganese dioxide nanoparticlesoxygen supply strategysonodynamic/chemodynamic therapytumor hypoxia alleviation

Substanzen

polydopamineOxygenChlorophyllidesphytochlorinManganese CompoundsIndolesOxidesPolymersPorphyrinsmanganese dioxide

Autor:innen und Institutionen

  • School of Medical Imaging, Xuzhou Medical University, Xuzhou, Jiangsu, 221004, China.
  • State Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Medical University, Chongqing, 400016, China.
  • Medical imaging department, Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, 221004, China.
  • Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, Hunan, 410013, China.
  • Jiangsu Medical Imaging and Digital Medical Engineering Research Center, Xuzhou, Jiangsu, 221004, China.

ORCID-Profile: Zhenbao Liu, Meilin Shi

Förderung

  • National Natural Science Foundation of China
  • China Postdoctoral Science Foundation
  • Postdoctoral Research Funding Program of Jiangsu Province
  • Xuzhou innovation project

Zitieren

APA

Cui, H., Ni, C., Wang, M., Huang, J., Qu, D., Yang, J., Pan, X., Liu, Z., & Shi, M. (2026). Smart Tumor Oxygen Supply Strategy Enables Dual‐Modality Fluorescence/MR Imaging and Synergistic Therapy of Triple‐Negative Breast Cancer. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202503886

Vancouver

Cui H, Ni C, Wang M, Huang J, Qu D, Yang J, et al. Smart Tumor Oxygen Supply Strategy Enables Dual‐Modality Fluorescence/MR Imaging and Synergistic Therapy of Triple‐Negative Breast Cancer. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.202503886

BibTeX
@article{Cui2026,
  author = {Cui, Hao and Ni, Chen and Wang, Mengmeng and Huang, Jie and Qu, Danyang and Yang, Jinfeng and Pan, Xingqi and Liu, Zhenbao and Shi, Meilin},
  title = {Smart Tumor Oxygen Supply Strategy Enables Dual‐Modality Fluorescence/MR Imaging and Synergistic Therapy of Triple‐Negative Breast Cancer},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  doi = {10.1002/adhm.202503886}
}
Kostenlos starten →